Related Experiment Video
Updated: Oct 26, 2025

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Hereditary angioedema.
1Department of Otolaryngology-Head and Neck Surgery, Philadelphia College of Osteopathic Medicine, 4190 City Line Avenue, Philadelphia, PA, 19131, USA.
A young patient experienced sudden lip swelling due to a rare C1 esterase inhibitor gene mutation, a form of hereditary angioedema. Prompt medical care improved symptoms but genetic testing confirmed the underlying cause.
Area of Science:
- Pediatrics
- Genetics
- Emergency Medicine
Background:
- Angioedema presents as localized, non-pitting edema affecting the skin, subcutaneous, and submucosal tissues.
- Commonly affects the lips, face, mouth, and throat, with potential for laryngeal involvement.
Purpose of the Study:
- To report a case of angioedema in a pediatric patient.
- To highlight the diagnostic process and genetic findings in a case of de novo C1 esterase inhibitor mutation.
Main Methods:
- Clinical presentation and examination of a 14-year-old female with acute lip swelling.
- Nasopharyngeal laryngoscopy to assess airway patency.
- Initiation of intravenous dexamethasone, famotidine, and diphenhydramine.
- Genetic testing to identify the underlying cause.
Main Results:
- The patient presented with sudden-onset upper lip edema.
- Initial treatment provided partial symptom relief.
- Nasopharyngeal laryngoscopy confirmed a patent airway.
- Genetic analysis revealed a de novo C1 esterase inhibitor gene mutation.
Conclusions:
- Sudden lip swelling in pediatric patients warrants thorough investigation for angioedema.
- A de novo C1 esterase inhibitor gene mutation can manifest as acute angioedema.
- Early diagnosis and genetic identification are crucial for appropriate management of hereditary angioedema.
Related Concept Videos
Genetic Lingo
Aneurysm I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Allergic Reactions
Angina I: Introduction
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

